Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) – 2021 to 2026

$3,850.00$5,850.00

Published on: July 17, 2021
Clear
SKU: GMS-2046 Category:

OVERVIEW

Amid the COVID-19 outbreak, the global stem cell therapy market is expected to hit USD 322.5 million by 2026, growing at a CAGR of 11.3% during the forecast period. Factors such as increasing number of scientific research activities focused on utilizing the therapeutic potency of stem cells for disease treatment, and the introduction of stem cell line banking and development of induced pluripotent stem cell (iPSC) lines are propelling the market growth. In the following report, the impact of the COVID-19 outbreak on the industry will be fully assessed. The reports also compares the markets of Pre COVID-19 and Post COVID-19.

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 1

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 2

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 3

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 4

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 5

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 6

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 7

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Stem Cell Therapy Market – Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries

2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Stem Cell Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
3.4 Top 5 Financials Analysis
4 Global Stem Cell Therapy Market – Market Forces
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Challenges
4.3 Porters Analysis of Market
4.3.1 Bargaining power of suppliers

4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5 Global Stem Cell Therapy Market – By Type (Market Size – & million/billion)
5.1 Allogeneic Stem Cell Therapy Market, By Application
5.2 Autologous Market
6 Global Stem Cell Therapy Market – By Cell Source
6.1 Adipose Tissue-Derived Mesenchymal Stem Cells
6.2 Bone Marrow-Derived Mesenchymal Stem Cells
6.3 Cord Blood/Embryonic Stem Cells
6.4 Others
7 Global Stem Cell Therapy Market – By Therapeutic Application
7.1 Cardiovascular Diseases
7.2 Surgeries
7.3 Musculoskeletal Disorders
7.4 Wounds and Injuries
7.5 Gastrointestinal Diseases
7.6 Others
8 Global Stem Cell Therapy Market – By Geography (Market Size – & million/billion)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 U.K
8.3.2 Germany
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan

8.4.3 India
8.4.4 South Korea
8.4.5 Rest of APAC
8.5 Rest of the World
8.5.1 South America
8.5.2 Middle East
8.5.3 Africa
9 Global Stem Cell Therapy Market – Entropy
9.1 New product launches
9.2 M&A's, collaborations, JVs and partnerships
10 Global Stem Cell Therapy Market -Company Profile (Key Players)
10.1 Market Share, Company Revenue, Products, M&A, Developments
10.2 Osiris Therapeutics, Inc.
10.3 MEDIPOST Co., Ltd.
10.4 Anterogen Co., Ltd.
10.5 RTI Surgical, Inc.
10.6 Allosource
10.7 Cellectis
10.8 Pharmicell Co., Ltd.
10.9 Holostem Terapie Avanzate SRL
10.10 JCR Pharmaceuticals Co., Ltd.
10.11 NuVasive, Inc.
10.12 Company 11 & more
11 Global Stem Cell Therapy Market – Appendix
11.1 Sources
11.2 Abbreviations